Oscar Health, Inc. (NYSE:OSCR - Get Free Report) was the target of unusually large options trading on Tuesday. Traders purchased 20,164 call options on the company. This represents an increase of 81% compared to the average daily volume of 11,150 call options.
Insider Buying and Selling
In other Oscar Health news, Director Elbert O. Jr. Robinson sold 25,000 shares of the firm's stock in a transaction that occurred on Monday, May 12th. The stock was sold at an average price of $16.43, for a total value of $410,750.00. Following the completion of the transaction, the director now directly owns 64,512 shares in the company, valued at $1,059,932.16. This trade represents a 27.93% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 24.39% of the stock is owned by corporate insiders.
Hedge Funds Weigh In On Oscar Health
A number of hedge funds have recently modified their holdings of the business. Vanguard Group Inc. raised its position in shares of Oscar Health by 3.7% in the 1st quarter. Vanguard Group Inc. now owns 19,698,442 shares of the company's stock worth $258,247,000 after acquiring an additional 700,469 shares in the last quarter. Deerfield Management Company L.P. Series C grew its holdings in Oscar Health by 50.7% during the fourth quarter. Deerfield Management Company L.P. Series C now owns 11,835,000 shares of the company's stock worth $159,062,000 after buying an additional 3,983,325 shares in the last quarter. T. Rowe Price Investment Management Inc. raised its holdings in shares of Oscar Health by 4.1% in the first quarter. T. Rowe Price Investment Management Inc. now owns 11,826,245 shares of the company's stock valued at $155,043,000 after purchasing an additional 467,301 shares during the last quarter. JPMorgan Chase & Co. increased its stake in Oscar Health by 348.7% in the 4th quarter. JPMorgan Chase & Co. now owns 10,360,529 shares of the company's stock valued at $139,246,000 after buying an additional 8,051,379 shares during the last quarter. Finally, Thrive Capital Management LLC lifted its holdings in Oscar Health by 33.4% during the fourth quarter. Thrive Capital Management LLC now owns 6,343,617 shares of the company's stock worth $85,258,000 after acquiring an additional 1,588,395 shares during the period. Institutional investors and hedge funds own 75.70% of the company's stock.
Oscar Health Price Performance
NYSE OSCR traded down $0.24 on Friday, hitting $15.41. 14,469,756 shares of the company's stock were exchanged, compared to its average volume of 4,632,010. Oscar Health has a 52 week low of $11.20 and a 52 week high of $23.79. The stock has a 50-day moving average of $13.87 and a 200-day moving average of $14.54. The company has a current ratio of 0.73, a quick ratio of 0.73 and a debt-to-equity ratio of 0.26. The stock has a market cap of $3.92 billion, a price-to-earnings ratio of -770.11 and a beta of 1.73.
Oscar Health (NYSE:OSCR - Get Free Report) last posted its quarterly earnings results on Wednesday, May 7th. The company reported $0.92 earnings per share for the quarter, beating analysts' consensus estimates of $0.83 by $0.09. The company had revenue of $3 billion for the quarter, compared to the consensus estimate of $2.87 billion. Oscar Health had a net margin of 0.28% and a return on equity of 2.28%. The firm's quarterly revenue was up 42.2% compared to the same quarter last year. During the same period last year, the company posted $0.62 EPS. Analysts expect that Oscar Health will post 0.69 earnings per share for the current year.
Analyst Upgrades and Downgrades
Several equities research analysts recently issued reports on the stock. Wells Fargo & Company downgraded shares of Oscar Health from an "overweight" rating to an "equal weight" rating and cut their target price for the company from $20.00 to $16.00 in a research note on Thursday, March 13th. Wall Street Zen upgraded shares of Oscar Health from a "hold" rating to a "buy" rating in a research report on Saturday, May 31st. Two equities research analysts have rated the stock with a sell rating, two have given a hold rating and two have assigned a buy rating to the stock. Based on data from MarketBeat.com, Oscar Health presently has a consensus rating of "Hold" and an average target price of $18.50.
View Our Latest Report on Oscar Health
About Oscar Health
(
Get Free Report)
Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.
Read More
Before you consider Oscar Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oscar Health wasn't on the list.
While Oscar Health currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.